210 If at first you don't succeed …switching treatments in NTRK fusion NSCLC

We describe a young patient treated with NTRK inhibitors with a remarkable response, albeit requiring a drug switch due to severe hepatotoxicity.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Deborah Scott, Tom Geldart Tags: Case Reports Source Type: research